Journal of Medical Economics, Volume 23, Issue 1 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 23, Issue 1 (2020)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Volume 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Rheumatology

Article
Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States
Furaha Kariburyo, Lin Xie, Janvi Sah, Nan Li & Jennifer H. Lofland
Pages: 1-9
Published online: 21 Oct 2019
AbstractforReal-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States | Full Text | References | PDF (976.6 KB) | EPUB
  • 3012 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access

Gastroenterology

Article
Prospective cost analysis of early video capsule endoscopy versus standard of care in non-hematemesis gastrointestinal bleeding: a non-inferiority study
Salmaan Jawaid, Neil B. Marya, Michelle Hicks, Christopher Marshall, Kanishka Bhattacharya & David Cave
Pages: 10-16
Published online: 15 Oct 2019
AbstractforProspective cost analysis of early video capsule endoscopy versus standard of care in non-hematemesis gastrointestinal bleeding: a non-inferiority study | Full Text | References | PDF (742.6 KB) | EPUB | Supplemental
  • 1154 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Humanistic and economic burden among caregivers of patients with cancer in Japan
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru & Katsura Tsukamoto
Pages: 17-27
Published online: 15 Oct 2019
AbstractforHumanistic and economic burden among caregivers of patients with cancer in Japan | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 1498 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma
Ali McBride, Andriy Krendyukov, Nicola Mathieson, Kim Campbell, Sanjeev Balu, Maja Natek, Karen MacDonald & Ivo Abraham
Pages: 28-36
Published online: 03 Sep 2019
AbstractforFebrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma | Full Text | References | PDF (894.6 KB) | EPUB
  • 4009 Views
  • 14 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
Alison Stopeck, Adam Brufsky, Lisa Kennedy, Sumi Bhatta, Debajyoti Bhowmik, Jacqueline Buchanan, Nicolas Despiegel & Guy Hechmati
Pages: 37-47
Published online: 26 Aug 2019
AbstractforCost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States | Full Text | References | PDF (1.7 MB) | EPUB
  • 5331 Views
  • 14 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States
Carl Samuelsen, Jonathan Lim, Amanda Golembesky, Sulena Shrestha, Li Wang & Ingolf Griebsch
Pages: 48-53
Published online: 09 Aug 2019
AbstractforHealthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States | Full Text | References | PDF (818.1 KB) | EPUB | Supplemental
  • 2826 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Total cost of care for castration-resistant prostate cancer in a commercially insured population and a medicare supplemental insured population
Bingcao Wu, Sophia S. Li, Ji Song, Christopher D. Pericone, Ajay S. Behl & Nancy A. Dawson
Pages: 54-63
Published online: 18 Oct 2019
AbstractforTotal cost of care for castration-resistant prostate cancer in a commercially insured population and a medicare supplemental insured population | Full Text | References | PDF (1.4 MB) | EPUB
  • 1991 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Allergic Diseases

Article
A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial
Katherine Dick, Andrew Briggs, Robert Ohsfeldt, Tobias Sydendal Grand & Sarah Buchs
Pages: 64-69
Published online: 10 Aug 2019
AbstractforA quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial | Full Text | References | PDF (913.7 KB) | EPUB
  • 1448 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

Neurology

Article
Economic burden of spinal muscular atrophy in the United States: a contemporary assessment
Marcus Droege, Douglas Sproule, Ramesh Arjunji, Marjolaine Gauthier-Loiselle, Martin Cloutier & Omar Dabbous
Pages: 70-79
Published online: 04 Aug 2019
AbstractforEconomic burden of spinal muscular atrophy in the United States: a contemporary assessment | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 5917 Views
  • 29 CrossRef citations
  • 0Altmetric
Open Access

Immunology

Article
Number needed to treat and cost per remitter for biologic treatments of Crohn’s disease in Japan
Fumiaki Ueno, Michio Doi, Yumi Kawai, Naoto Ukawa, Jordan Cammarota & Keith A. Betts
Pages: 80-85
Published online: 13 Aug 2019
AbstractforNumber needed to treat and cost per remitter for biologic treatments of Crohn’s disease in Japan | Full Text | References | PDF (589 KB) | EPUB
  • 2880 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Infectious Disease

Article
The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom
Lefteris Floros, Antonio Pagliuca, Amer Al Taie, Diana Weidlich, Maria Rita Capparella, Mihalina Georgallis & Anita Hor-Yun Sung
Pages: 86-97
Published online: 09 Jul 2019
AbstractforThe cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 3911 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access

Diabetes

Article
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK
Stephen C. Bain, Brian Bekker Hansen, Barnaby Hunt, Barrie Chubb & William J. Valentine
Pages: 98-105
Published online: 02 Aug 2019
AbstractforEvaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 7441 Views
  • 19 CrossRef citations
  • 0Altmetric
Open Access

Ophthalmology

Article
The cost burden of falls in people with glaucoma in National Health Service Hospital Trusts in the UK
Patrick McGinley, Ejaz Ansari, Harjit Sandhu & Tricia Dixon
Pages: 106-112
Published online: 13 Aug 2019
AbstractforThe cost burden of falls in people with glaucoma in National Health Service Hospital Trusts in the UK | Full Text | References | PDF (699 KB) | EPUB
  • 3679 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access

Pain

Article
Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK
Georgia Hollier-Hann, Alistair Curry, Kateryna Onishchenko, Ron Akehurst, Fayyaz Ahmed, Brendan Davies & Ian Keyzor
Pages: 113-123
Published online: 04 Nov 2019
AbstractforUpdated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK | Full Text | References | PDF (1.5 MB) | EPUB
  • 1719 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

The efficiency of TAVI in intermediate and low-risk Japanese patients.
Panagiotis Petrou
Editorial | Published online: 25 May 2024
Open Access
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
Mafalda Ramos et al.
Article | Published online: 17 May 2024
Open Access
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 13 May 2024
Open Access
Balancing innovation and ethics in AI governance for health technology assessment
João L. Carapinha et al.
Editorial | Published online: 13 May 2024
Open Access
View all latest articles